Harry, your sage comments are spot-on correct. While the man on the street may think of these as generic like - they are not. There will be a steep learning curve to their use and acceptance. Your comments should be the beginning of a "Fact Sheet" the ACR or RheumNow can draw up to explain what a biosimilar is. Thanks for keeping me straight!